Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insight Molecular Diagnostics Inc (IMDX)

Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Insight Molecular Diagnostics Inc 2 INTERNATIONAL PLAZA DR. SUITE 510 NASHVILLE TN 37217 USA

https://imdxinc.com Employees: 49 P: 615-255-8880

Sector:

Medical

Description:

Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.

Key Statistics

Overview:

Market Capitalization, $K 190,329
Enterprise Value, $K 181,689
Shares Outstanding, K 28,664
Float, K 28,076
% Float 97.95%
Short Interest, K 204
Short Float 0.71%
Days to Cover 4.75
Short Volume Ratio 0.52
% of Insider Shareholders 2.05%
% of Institutional Shareholders 55.35%

Financials:

Annual Sales, $ 1,880 K
Annual Net Income, $ -60,660 K
Last Quarter Sales, $ 260 K
Last Quarter Net Income, $ -10,850 K
EBIT, $ -19,420 K
EBITDA, $ -17,860 K

Growth:

1-Year Return 209.72%
3-Year Return -15.48%
5-Year Return -94.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 83.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/10/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -0.42
EPS Growth vs. Prev Qtr -13.33%
EPS Growth vs. Prev Year 65.31%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/25/23

IMDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -39.77%
Profit Margin % -3,226.60%
Debt/Equity 0.00
Price/Sales 40.44
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.32
Interest Coverage -757.25
60-Month Beta 1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar